Access to High-Cost Medications After a Cap on Monthly Out-of-Pocket Spending in California

Erin Audrey Taylor, Christine Buttorff, Vishaal Pegany, Lindsay Petersen, Allison Mangiaracino, Emory Wolf, Lance Lang

ResearchPosted on rand.org Mar 4, 2022Published in: JAMA Network Open, Volume 4, No. 9 (September 2021). doi: 10.1001/jamanetworkopen.2021.26642

High prescription drug costs are a substantial problem for many patients who cannot afford their medications, even with health insurance. Capping monthly out-of-pocket (OOP) costs for high-cost drugs may increase the affordability of these medications. In January 2016, Covered California implemented a monthly cap on OOP costs for high-cost drugs to increase patient access. We evaluated the association of this cap with high-cost drug use and OOP spending.

Read More

Topics

Document Details

  • Copyright: Erin Audrey Taylor, Christine Buttorff, Vishaal Pegany, Lindsay Petersen, Allison Mangiaracino, Emory Wolf, Lance Lang ; Open Access
  • Publisher: JAMA Network
  • Availability: Non-RAND
  • Year: 2021
  • Pages: 3
  • Document Number: EP-68875

Research conducted by

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.